<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34198557</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6352</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22126352</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease of the motor system. It is characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and paralysis. ALS is incurable and has a bleak prognosis, with median survival of 3-5 years after the initial symptomatology. In ALS, motor neurons gradually degenerate and die. Many features of mitochondrial dysfunction are manifested in neurodegenerative diseases, including ALS. Mitochondria have shown to be an early target in ALS pathophysiology and contribute to disease progression. Disruption of their axonal transport, excessive generation of reactive oxygen species, disruption of the mitochondrial structure, dynamics, mitophagy, energy production, calcium buffering and apoptotic triggering have all been directly involved in disease pathogenesis and extensively reported in ALS patients and animal model systems. Alterations in energy production by motor neurons, which severely limit their survival capacity, are tightly linked to the redox status and mitochondria. The present review focuses on this link. Placing oxidative stress as a main pathophysiological mechanism, the molecular interactions and metabolic flows involved are analyzed. This leads to discussing potential therapeutic approaches targeting mitochondrial biology to slow disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Obrador</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5934-5543</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, 15 Av. Blasco Iba&#xf1;ez, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvador-Palmer</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0784-6776</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, 15 Av. Blasco Iba&#xf1;ez, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Blanch</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, 15 Av. Blasco Iba&#xf1;ez, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jihad-Jebbar</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, 15 Av. Blasco Iba&#xf1;ez, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vall&#xe9;s</LastName><ForeName>Soraya L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0003-4861-4266</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, 15 Av. Blasco Iba&#xf1;ez, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estrela</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, 15 Av. Blasco Iba&#xf1;ez, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OTR2017-18255INVES</GrantID><Agency>Universitat de Val&#xe8;ncia</Agency><Country/></Grant><Grant><GrantID>OTR2018-19337INVES</GrantID><Agency>Elysium Health Inc., USA</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="Y">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">bioenergetics</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">redox status</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34198557</ArticleId><ArticleId IdType="pmc">PMC8231819</ArticleId><ArticleId IdType="doi">10.3390/ijms22126352</ArticleId><ArticleId IdType="pii">ijms22126352</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Brent J.R., Franz C.K., Coleman J.M., Ajroud-Driss S. ALS: Management problems. Neurol. Clin. 2020;38:565&#x2013;575. doi: 10.1016/j.ncl.2020.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2020.03.013</ArticleId><ArticleId IdType="pmc">PMC7963888</ArticleId><ArticleId IdType="pubmed">32703469</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei K., Tsuda K., Takahashi F., Hirai M., Palumbo J. An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe. Amyotroph. Lateral Scler. Front. Degener. 2017;18:88&#x2013;97. doi: 10.1080/21678421.2017.1361445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1361445</ArticleId><ArticleId IdType="pubmed">28872912</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H., Cheng B., Katz I.B., Pinto M., Hays A.P., Mitsumoto H., Rowland L.P. The natural history of primary lateral sclerosis. Neurology. 2006;66:647&#x2013;653. doi: 10.1212/01.wnl.0000200962.94777.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000200962.94777.71</ArticleId><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler D., Poncet A., Iancu Ferfoglia R., Truffert A., Janssens J.-P. Predicting respiratory failure in amyotrophic lateral sclerosis: Still a long way to go. Eur. Respir. J. 2019;54 doi: 10.1183/13993003.01065-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01065-2019</ArticleId><ArticleId IdType="pubmed">31371441</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O., Kiernan M.C., Chi&#xf2; A., Rix-Brooks B., van den Berg L.H. Amyotrophic lateral sclerosis: Moving towards a new classification system. Lancet Neurol. 2016;15:1182&#x2013;1194. doi: 10.1016/S1474-4422(16)30199-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30199-5</ArticleId><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., Gil-Bea F.J., Santurtun A., L&#xf3;pez de Muna&#xed;n A. Amyotrophic lateral sclerosis: A complex syndrome that needs an integrated research approach. Neural Regen. Res. 2019;14:193&#x2013;196. doi: 10.4103/1673-5374.244783.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.244783</ArticleId><ArticleId IdType="pmc">PMC6301158</ArticleId><ArticleId IdType="pubmed">30530996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS genetics, mechanisms, and therapeutics: Where are we now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk A.E., Weishaupt J.H., Andersen P.M., Ludolph A.C., Kubisch C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med. Genet. 2018;30:252&#x2013;258. doi: 10.1007/s11825-018-0185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11825-018-0185-3</ArticleId><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S., Al Khleifat A., Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Research. 2017;6:371. doi: 10.12688/f1000research.10476.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.10476.1</ArticleId><ArticleId IdType="pmc">PMC5373425</ArticleId><ArticleId IdType="pubmed">28408982</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L., Cookson M.R., Petrucelli L., La Spada A.R. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat. Neurosci. 2018;21:1300&#x2013;1309. doi: 10.1038/s41593-018-0237-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0237-7</ArticleId><ArticleId IdType="pmc">PMC6278826</ArticleId><ArticleId IdType="pubmed">30258237</ArticleId></ArticleIdList></Reference><Reference><Citation>Granatiero V., Manfredi G. Mitochondrial transport and turnover in the pathogenesis of amyotrophic lateral sclerosis. Biology. 2019;8:36. doi: 10.3390/biology8020036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology8020036</ArticleId><ArticleId IdType="pmc">PMC6627920</ArticleId><ArticleId IdType="pubmed">31083575</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali&#xf3; M.L., Henriques E., Siena A., Bertoncini C.R.A., Gil-Mohapel J., Rosenstock T.R. Mitochondrial dysfunction, neurogenesis, and epigenetics: Putative implications for amyotrophic lateral sclerosis neurodegeneration and treatment. Front. Neurosci. 2020;14:679. doi: 10.3389/fnins.2020.00679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00679</ArticleId><ArticleId IdType="pmc">PMC7373761</ArticleId><ArticleId IdType="pubmed">32760239</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrador E., Salvador R., L&#xf3;pez-Blanch R., Jihad-Jebbar A., Vall&#xe9;s S.L., Estrela J.M. Oxidative stress, neuroinflammation and mitochondria in the pathophysiology of amyotrophic lateral sclerosis. Antioxidants. 2020;9:901. doi: 10.3390/antiox9090901.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9090901</ArticleId><ArticleId IdType="pmc">PMC7555310</ArticleId><ArticleId IdType="pubmed">32971909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007;66:10&#x2013;16. doi: 10.1097/nen.0b013e31802c396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31802c396b</ArticleId><ArticleId IdType="pubmed">17204932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann F.R., Manfredi G., Mawrin C., Beal M.F., Schon E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002;80:616&#x2013;625. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death. Ann. Neurol. 1999;46:787&#x2013;790. doi: 10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moura M.B., dos Santos L.S., Van Houten B. Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ. Mol. Mutagen. 2010;51:391&#x2013;405. doi: 10.1002/em.20575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/em.20575</ArticleId><ArticleId IdType="pubmed">20544881</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriedo S.G., Sensi S.L., Yin H.Z., Weiss J.H. AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro. J. Neurosci. 2000;20:240&#x2013;250. doi: 10.1523/JNEUROSCI.20-01-00240.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-01-00240.2000</ArticleId><ArticleId IdType="pmc">PMC6774118</ArticleId><ArticleId IdType="pubmed">10627601</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.U., Saw N.L., Vogel H., Cunnigham A.D., Shamloo M., Mochly-Rosen D. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol. Med. 2018;10 doi: 10.15252/emmm.201708166.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708166</ArticleId><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Babbar M., Sheikh M.S. Metabolic stress and disorders related to alterations in mitochondrial fission or fusion. Mol. Cell Pharmacol. 2013;5:109&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3921894</ArticleId><ArticleId IdType="pubmed">24533171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sassani M., Alix J.J., McDermott C.J., Baster K., Hoggard N., Wild J.M., Mortiboys H.J., Shaw P.J., Wilkinson I.D., Jenkins T.M. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis. Brain. 2020;143:3603&#x2013;3618. doi: 10.1093/brain/awaa340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa340</ArticleId><ArticleId IdType="pubmed">33439988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacorte E., Ferrigno L., Leoncini E., Corbo M., Boccia S., Vanacore N. Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review. Neurosci. Biobehav. Rev. 2016;66:61&#x2013;79. doi: 10.1016/j.neubiorev.2016.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2016.04.007</ArticleId><ArticleId IdType="pubmed">27108217</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood C.A., Westgate K., Gunstone S., Brage S., Wareham N.J., McDermott C.J., Shaw P.J. Long-term physical activity: An exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. Front. Degener. 2016;17:377&#x2013;384. doi: 10.3109/21678421.2016.1154575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1154575</ArticleId><ArticleId IdType="pmc">PMC4950417</ArticleId><ArticleId IdType="pubmed">26998882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostojic S.M., Ratgeber L., Olah A., Betlehem J., Pongras A. What do over-trained athletes and patients with neurodegenerative diseases have in common? Mitochondrial dysfunction. Exp. Biol. Med. 2021:1535370221990619. doi: 10.1177/1535370221990619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370221990619</ArticleId><ArticleId IdType="pubmed">33554650</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard M., McEwen B.S. Psychological stress and mitochondria: A conceptual framework. Psychosom. Med. 2018;80:126&#x2013;140. doi: 10.1097/PSY.0000000000000544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000544</ArticleId><ArticleId IdType="pmc">PMC5901651</ArticleId><ArticleId IdType="pubmed">29389735</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin Kullmann J.A., Hayes S., Pamphlett R. Is psychological stress a predisposing factor for amyotrophic lateral sclerosis (ALS)? An online international case-control study of premorbid life events, occupational stress, resilience and anxiety. PLoS ONE. 2018;13:e0204424. doi: 10.1371/journal.pone.0204424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0204424</ArticleId><ArticleId IdType="pmc">PMC6150536</ArticleId><ArticleId IdType="pubmed">30240431</ArticleId></ArticleIdList></Reference><Reference><Citation>Putcha G.V., Harris C.A., Moulder K.L., Easton R.M., Thompson C.B., Johnson E.M. Intrinsic and extrinsic pathway signaling during neuronal apoptosis: Lessons from the analysis of mutant mice. J. Cell Biol. 2002;157:441&#x2013;453. doi: 10.1083/jcb.200110108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200110108</ArticleId><ArticleId IdType="pmc">PMC2173286</ArticleId><ArticleId IdType="pubmed">11980919</ArticleId></ArticleIdList></Reference><Reference><Citation>Henshall D.C., Bonislawski D.P., Skradski S.L., Lan J.Q., Meller R., Simon R.P. Cleavage of bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures. Neurobiol. Dis. 2001;8:568&#x2013;580. doi: 10.1006/nbdi.2001.0415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0415</ArticleId><ArticleId IdType="pubmed">11493022</ArticleId></ArticleIdList></Reference><Reference><Citation>Syntichaki P., Tavernarakis N. The biochemistry of neuronal necrosis: Rogue biology? Nat. Rev. Neurosci. 2003;4:672&#x2013;684. doi: 10.1038/nrn1174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1174</ArticleId><ArticleId IdType="pubmed">12894242</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 1999;58:459&#x2013;471. doi: 10.1097/00005072-199905000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199905000-00005</ArticleId><ArticleId IdType="pubmed">10331434</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. P53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 2000;7:613&#x2013;622. doi: 10.1006/nbdi.2000.0314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0314</ArticleId><ArticleId IdType="pubmed">11114260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S., Bowser R. P53 and cell cycle proteins participate in spinal motor neuron cell death in ALS. Open Pathol. J. 2010;4:11&#x2013;22. doi: 10.2174/1874375701004010011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874375701004010011</ArticleId><ArticleId IdType="pmc">PMC3092395</ArticleId><ArticleId IdType="pubmed">21572928</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Agar J.N., Taylor D.M., Minotti S., Durham H.D. Focal dysfunction of the proteasome: A pathogenic factor in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2004;89:1325&#x2013;1335. doi: 10.1111/j.1471-4159.2004.02453.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02453.x</ArticleId><ArticleId IdType="pubmed">15189335</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes N.A., Fisher J.K., Austgen K., VandenBerg S., Huang E.J., Oakes S.A. Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. J. Clin. Investig. 2010;120:3673&#x2013;3679. doi: 10.1172/JCI42986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI42986</ArticleId><ArticleId IdType="pmc">PMC2947232</ArticleId><ArticleId IdType="pubmed">20890041</ArticleId></ArticleIdList></Reference><Reference><Citation>Re D.B., Le Verche V., Yu C., Amoroso M.W., Politi K.A., Phani S., Ikiz B., Hoffmann L., Koolen M., Nagata T., et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;1008. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Bell S., Wang J., Wen S., Baloh R.H., Appel S.H. TDP-43 activates microglia through NF-&#x39a;B and NLRP3 inflammasome. Exp. Neurol. 2015;273:24&#x2013;35. doi: 10.1016/j.expneurol.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: Cellular mechanisms and therapeutic implications. Front. Immunol. 2017;8:1005. doi: 10.3389/fimmu.2017.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Glial cells in amyotrophic lateral sclerosis. Exp. Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Johnson J.A. Astrogliosis in amyotrophic lateral sclerosis: Role and therapeutic potential of astrocytes. Neurotherapeutics. 2010;7:471&#x2013;481. doi: 10.1016/j.nurt.2010.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2010.05.012</ArticleId><ArticleId IdType="pmc">PMC2967019</ArticleId><ArticleId IdType="pubmed">20880509</ArticleId></ArticleIdList></Reference><Reference><Citation>Radford R.A., Morsch M., Rayner S.L., Cole N.J., Pountney D.L., Chung R.S. The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia. Front. Cell Neurosci. 2015;9:414. doi: 10.3389/fncel.2015.00414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00414</ArticleId><ArticleId IdType="pmc">PMC4621294</ArticleId><ArticleId IdType="pubmed">26578880</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Petzold A., S&#xfc;ssmuth S.D., Ludolph A.C., Tumani H. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology. 2006;66:852&#x2013;856. doi: 10.1212/01.wnl.0000203120.85850.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000203120.85850.54</ArticleId><ArticleId IdType="pubmed">16567701</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S., Debska-Vielhaber G., Abdulla S., Machts J., Schreiber F., Kropf S., K&#xd6;rtvelyessy P., K&#xd6;rner S., Kollewe K., Petri S., et al. Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis. Muscle Nerve. 2018;57:273&#x2013;278. doi: 10.1002/mus.25682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25682</ArticleId><ArticleId IdType="pubmed">28472860</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., McLean J., Robertson J. Neuronal intermediate filaments and ALS: A new look at an old question. Biochim. Biophys. Acta. 2006;1762:1001&#x2013;1012. doi: 10.1016/j.bbadis.2006.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.09.003</ArticleId><ArticleId IdType="pubmed">17045786</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Huang M., Shang D., Yan X., Zhao B., Zhang X. Mitochondrial behavior in axon degeneration and regeneration. Front. Aging Neurosci. 2021;13:650038. doi: 10.3389/fnagi.2021.650038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.650038</ArticleId><ArticleId IdType="pmc">PMC7982458</ArticleId><ArticleId IdType="pubmed">33762926</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A.R., Gregory J.M., Dando O., Carter R.N., Burr K., Nanda J., Story D., McDade K., Smith C., Morton N.M., et al. Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis. Acta Neuropathol. 2021;141:257&#x2013;279. doi: 10.1007/s00401-020-02252-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02252-5</ArticleId><ArticleId IdType="pmc">PMC7847443</ArticleId><ArticleId IdType="pubmed">33398403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J., Wu P.-H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.-Y., Mootha V.K., J&#xe4;ger S., Vianna C.R., Reznick R.M., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell. 2004;119:121&#x2013;135. doi: 10.1016/j.cell.2004.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.09.013</ArticleId><ArticleId IdType="pubmed">15454086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan-Olive M.M., Lauritzen K.H., Ali M., Rasmussen L.J., Storm-Mathisen J., Bergersen L.H. A ketogenic diet improves mitochondrial biogenesis and bioenergetics via the PGC1&#x3b1;-SIRT3-UCP2 axis. Neurochem. Res. 2019;44:22&#x2013;37. doi: 10.1007/s11064-018-2588-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2588-6</ArticleId><ArticleId IdType="pubmed">30027365</ArticleId></ArticleIdList></Reference><Reference><Citation>Rius-P&#xe9;rez S., Torres-Cuevas I., Mill&#xe1;n I., Ortega &#xc1;.L., P&#xe9;rez S. PGC-1&#x3b1;, inflammation, and oxidative stress: An integrative view in metabolism. Oxid. Med. Cell Longev. 2020;2020:1452696. doi: 10.1155/2020/1452696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/1452696</ArticleId><ArticleId IdType="pmc">PMC7085407</ArticleId><ArticleId IdType="pubmed">32215168</ArticleId></ArticleIdList></Reference><Reference><Citation>Filiano A.J., Gadani S.P., Kipnis J. Interactions of innate and adaptive immunity in brain development and function. Brain Res. 2015;1617:18&#x2013;27. doi: 10.1016/j.brainres.2014.07.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.07.050</ArticleId><ArticleId IdType="pmc">PMC4320678</ArticleId><ArticleId IdType="pubmed">25110235</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlke C., Saberi D., Ott B., Brand-Saberi B., Schmitt-John T., Theiss C. Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model. J. Neuroinflamm. 2015;12:215. doi: 10.1186/s12974-015-0435-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0435-0</ArticleId><ArticleId IdType="pmc">PMC4657283</ArticleId><ArticleId IdType="pubmed">26597538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777&#x2013;783. doi: 10.1126/science.aag2590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aag2590</ArticleId><ArticleId IdType="pubmed">27540165</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Riani M., D&#xed;az-Amarilla P., Isasi E., Casanova G., Barbeito L., Olivera-Bravo S. Ultrastructural features of aberrant glial cells isolated from the spinal cord of paralytic rats expressing the amyotrophic lateral sclerosis-linked SOD1G93A mutation. Cell Tissue Res. 2017;370:391&#x2013;401. doi: 10.1007/s00441-017-2681-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-017-2681-1</ArticleId><ArticleId IdType="pubmed">28864831</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-&#x39a;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra P.-S., Dhull D.K., Nalini A., Vijayalakshmi K., Sathyaprabha T.N., Alladi P.A., Raju T.R. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J. Neuroinflamm. 2016;13:212. doi: 10.1186/s12974-016-0698-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0698-0</ArticleId><ArticleId IdType="pmc">PMC5006495</ArticleId><ArticleId IdType="pubmed">27578023</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Mart&#xed;nez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo M., Chiasserini D., Tozzi A., Picconi B., Calabresi P. Mitochondria and the link between neuroinflammation and neurodegeneration. J. Alzheimer Dis. 2010;20(Suppl. S2):S369&#x2013;S379. doi: 10.3233/JAD-2010-100543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-100543</ArticleId><ArticleId IdType="pubmed">20463396</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Swerdlow R.H. Relationships between mitochondria and neuroinflammation: Implications for Alzheimer&#x2019;s disease. Curr. Top. Med. Chem. 2016;16:849&#x2013;857. doi: 10.2174/1568026615666150827095102.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026615666150827095102</ArticleId><ArticleId IdType="pmc">PMC5480219</ArticleId><ArticleId IdType="pubmed">26311426</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes J.A., Davies M.C., Collins M.O. TBK1: A new player in ALS linking autophagy and neuroinflammation. Mol. Brain. 2017;10:5. doi: 10.1186/s13041-017-0287-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.U., Minhas P.S., Liddelow S.A., Haileselassie B., Andreasson K.I., Dorn G.W., Mochly-Rosen D. Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat. Neurosci. 2019;22:1635&#x2013;1648. doi: 10.1038/s41593-019-0486-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0486-0</ArticleId><ArticleId IdType="pmc">PMC6764589</ArticleId><ArticleId IdType="pubmed">31551592</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrador E., Salvador R., Marchio P., L&#xf3;pez-Blanch R., Jihad-Jebbar A., Rivera P., Vall&#xe9;s S.L., Banacloche S., Alc&#xe1;cer J., Colomer N. Nicotinamide riboside and pterostilbene cooperatively delay motor neuron failure in ALS SOD1 G93A mice. Mol. Neurobiol. 2020;58:1345&#x2013;1371. doi: 10.1007/s12035-020-02188-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02188-7</ArticleId><ArticleId IdType="pubmed">33174130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sies H. Oxidative stress: A concept in redox biology and medicine. Redox Biol. 2015;4:180&#x2013;183. doi: 10.1016/j.redox.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2015.01.002</ArticleId><ArticleId IdType="pmc">PMC4309861</ArticleId><ArticleId IdType="pubmed">25588755</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambrosi N., Cozzolino M., Carr&#xec; M.T. Neuroinflammation in amyotrophic lateral sclerosis: Role of redox (Dys) regulation. Antioxid. Redox Signal. 2017;29:15&#x2013;36. doi: 10.1089/ars.2017.7271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7271</ArticleId><ArticleId IdType="pubmed">28895473</ArticleId></ArticleIdList></Reference><Reference><Citation>Carretero J., Obrador E., Esteve J.M., Ortega A., Pellicer J.A., Sempere F.V., Estrela J.M. Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. J. Biol. Chem. 2001;276:25775&#x2013;25782. doi: 10.1074/jbc.M101148200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M101148200</ArticleId><ArticleId IdType="pubmed">11313348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 1999;26:463&#x2013;471. doi: 10.1016/S0891-5849(98)00216-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(98)00216-0</ArticleId><ArticleId IdType="pubmed">9895239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons T.J., Liu H., Goto J.J., Nersissian A., Roe J.A., Graden J.A., Caf&#xe9; C., Ellerby L.M., Bredesen D.E., Gralla E.B., et al. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc. Natl. Acad. Sci. USA. 1996;93:12240&#x2013;12244. doi: 10.1073/pnas.93.22.12240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.22.12240</ArticleId><ArticleId IdType="pmc">PMC37974</ArticleId><ArticleId IdType="pubmed">8901564</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow J.P., Sampson J.B., Zhuang Y., Thompson J.A., Beckman J.S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 1997;69:1936&#x2013;1944. doi: 10.1046/j.1471-4159.1997.69051936.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69051936.x</ArticleId><ArticleId IdType="pubmed">9349538</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown D.R., Clive C., Haswell S.J. Antioxidant activity related to copper binding of native prion protein. J. Neurochem. 2001;76:69&#x2013;76. doi: 10.1046/j.1471-4159.2001.00009.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00009.x</ArticleId><ArticleId IdType="pubmed">11145979</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown D.R., Nicholas R.S.J., Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J. Neurosci. Res. 2002;67:211&#x2013;224. doi: 10.1002/jnr.10118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10118</ArticleId><ArticleId IdType="pubmed">11782965</ArticleId></ArticleIdList></Reference><Reference><Citation>Roucou X., Gains M., LeBlanc A.C. Neuroprotective functions of prion protein. J. Neurosci. Res. 2004;75:153&#x2013;161. doi: 10.1002/jnr.10864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10864</ArticleId><ArticleId IdType="pubmed">14705136</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown D.R. Neurodegeneration and oxidative stress: Prion disease results from loss of antioxidant defence. Folia Neuropathol. 2005;43:229&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">16416388</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136&#x2013;144. doi: 10.1126/science.6801762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6801762</ArticleId><ArticleId IdType="pubmed">6801762</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan F., Yang L., Zhang Z., Wu W., Zhou X., Yin X., Zhao D. Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases. J. Mol. Neurosci. 2013;51:219&#x2013;224. doi: 10.1007/s12031-013-0008-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-013-0008-6</ArticleId><ArticleId IdType="pmc">PMC3739867</ArticleId><ArticleId IdType="pubmed">23715697</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D.P., Sies H. The redox code. Antioxid. Redox Signal. 2015;23:734&#x2013;746. doi: 10.1089/ars.2015.6247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2015.6247</ArticleId><ArticleId IdType="pmc">PMC4580308</ArticleId><ArticleId IdType="pubmed">25891126</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiduschat N., Mao X., Hupf J., Armstrong N., Kang G., Lange D.J., Mitsumoto H., Shungu D.C. Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique. Neurosci. Lett. 2014;570:102&#x2013;107. doi: 10.1016/j.neulet.2014.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2014.04.020</ArticleId><ArticleId IdType="pubmed">24769125</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Johnson D.A., Johnson J.A. Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked HSOD1(G93A) mice model. Neurobiol. Dis. 2011;43:543&#x2013;551. doi: 10.1016/j.nbd.2011.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.04.025</ArticleId><ArticleId IdType="pmc">PMC3139005</ArticleId><ArticleId IdType="pubmed">21600285</ArticleId></ArticleIdList></Reference><Reference><Citation>Killoy K.M., Harlan B.A., Pehar M., Helke K.L., Johnson J.A., Vargas M.R. Decreased glutathione levels cause overt motor neuron degeneration in HSOD1WT over-expressing mice. Exp. Neurol. 2018;302:129&#x2013;135. doi: 10.1016/j.expneurol.2018.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.01.004</ArticleId><ArticleId IdType="pmc">PMC5849514</ArticleId><ArticleId IdType="pubmed">29307609</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz J., Parker S.J., Vella L.J., Ng D.C., Price K.A., Liddell J.R., Caragounis A., Li Q.-X., Masters C.L., Nonaka T., et al. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol. Neurodegener. 2011;6:57. doi: 10.1186/1750-1326-6-57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-57</ArticleId><ArticleId IdType="pmc">PMC3162576</ArticleId><ArticleId IdType="pubmed">21819629</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank E.M., Figueroa-Romero C., Hinder L.M., Bedi K., Archbold H.C., Li X., Weskamp K., Safren N., Paez-Colasante X., Pacut C., et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat. Commun. 2018;9:2845. doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Hwang A.W., Unger T., Trojanowski J.Q., Lee V.M.Y. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J. 2012;31:1241&#x2013;1252. doi: 10.1038/emboj.2011.471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.471</ArticleId><ArticleId IdType="pmc">PMC3297986</ArticleId><ArticleId IdType="pubmed">22193716</ArticleId></ArticleIdList></Reference><Reference><Citation>Shodai A., Morimura T., Ido A., Uchida T., Ayaki T., Takahashi R., Kitazawa S., Suzuki S., Shirouzu M., Kigawa T., et al. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 KDa (TDP-43) J. Biol. Chem. 2013;288:14886&#x2013;14905. doi: 10.1074/jbc.M113.451849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.451849</ArticleId><ArticleId IdType="pmc">PMC3663511</ArticleId><ArticleId IdType="pubmed">23558684</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Xie E.F., Kocak N., Ozdinler P.H. Mitoautophagy: A unique self-destructive path mitochondria of upper motor neurons with TDP-43 pathology take, very early in ALS. Front. Cell Neurosci. 2019;13:489. doi: 10.3389/fncel.2019.00489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00489</ArticleId><ArticleId IdType="pmc">PMC6854036</ArticleId><ArticleId IdType="pubmed">31787882</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.-F., Gendron T.F., Zhang Y.-J., Lin W.-L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Lu J., Siedlak S.L., Fujioka H., Liang J., Jiang S., Ma X., Jiang Z., da Rocha E.L., et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X., Zhou J., Li Y., Wu K., Chen Z., Luo Z., Zhang X., Liang Y., Esteban M.A., Zhou Y., et al. TDP-43 Aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat. Struct. Mol. Biol. 2021;28:132&#x2013;142. doi: 10.1038/s41594-020-00537-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00537-7</ArticleId><ArticleId IdType="pubmed">33398173</ArticleId></ArticleIdList></Reference><Reference><Citation>Stribl C., Samara A., Tr&#xfc;mbach D., Peis R., Neumann M., Fuchs H., Gailus-Durner V., Hrab&#x11b; de Angelis M., Rathkolb B., Wolf E., et al. Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43. J. Biol. Chem. 2014;289:10769&#x2013;10784. doi: 10.1074/jbc.M113.515940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.515940</ArticleId><ArticleId IdType="pmc">PMC4036193</ArticleId><ArticleId IdType="pubmed">24515116</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., De Vos K.J., Paillusson S., Mueller S., Sancho R.M., Lau K.-F., Vizcay-Barrena G., Lin W.-L., Xu Y.-F., Lewis J., et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun. 2014;5:3996. doi: 10.1038/ncomms4996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4996</ArticleId><ArticleId IdType="pmc">PMC4046113</ArticleId><ArticleId IdType="pubmed">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Boustany N.N., Drezek R., Thakor N.V. Calcium-induced alterations in mitochondrial morphology quantified in situ with optical scatter imaging. Biophys. J. 2002;83:1691&#x2013;1700. doi: 10.1016/S0006-3495(02)73937-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(02)73937-4</ArticleId><ArticleId IdType="pmc">PMC1302265</ArticleId><ArticleId IdType="pubmed">12202392</ArticleId></ArticleIdList></Reference><Reference><Citation>Denton R.M. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta. 2009;1787:1309&#x2013;1316. doi: 10.1016/j.bbabio.2009.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2009.01.005</ArticleId><ArticleId IdType="pubmed">19413950</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W., Li X., Shi J., Guo Y., Li Z., Li C. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience. 2010;169:1621&#x2013;1629. doi: 10.1016/j.neuroscience.2010.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.06.018</ArticleId><ArticleId IdType="pubmed">20600671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimoto T., Miyazaki K., Morimoto N., Kurata T., Satoh K., Ikeda Y., Abe K. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice. Brain Res. 2012;1446:109&#x2013;118. doi: 10.1016/j.brainres.2011.12.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.12.064</ArticleId><ArticleId IdType="pubmed">22353756</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Pehar M., Cassina P., Beckman J.S., Barbeito L. Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents P75NTR-dependent motor neuron apoptosis. J. Neurochem. 2006;97:687&#x2013;696. doi: 10.1111/j.1471-4159.2006.03742.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03742.x</ArticleId><ArticleId IdType="pubmed">16524372</ArticleId></ArticleIdList></Reference><Reference><Citation>Neymotin A., Calingasan N.Y., Wille E., Naseri N., Petri S., Damiano M., Liby K.T., Risingsong R., Sporn M., Beal M.F., et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2011;51:88&#x2013;96. doi: 10.1016/j.freeradbiomed.2011.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.03.027</ArticleId><ArticleId IdType="pmc">PMC3109235</ArticleId><ArticleId IdType="pubmed">21457778</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H.Z., Nalbandian A., Hsu C.-I., Li S., Llewellyn K.J., Mozaffar T., Kimonis V.E., Weiss J.H. Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice. Cell Death Dis. 2012;3:e374. doi: 10.1038/cddis.2012.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2012.115</ArticleId><ArticleId IdType="pmc">PMC3434652</ArticleId><ArticleId IdType="pubmed">22898872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolome F., Wu H.-C., Burchell V.S., Preza E., Wray S., Mahoney C.J., Fox N.C., Calvo A., Canosa A., Moglia C., et al. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron. 2013;78:57&#x2013;64. doi: 10.1016/j.neuron.2013.02.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.028</ArticleId><ArticleId IdType="pmc">PMC3843114</ArticleId><ArticleId IdType="pubmed">23498975</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Tong J., Bi F., Wu Q., Huang B., Zhou H., Xia X.-G. Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats. Hum. Mol. Genet. 2012;21:4602&#x2013;4614. doi: 10.1093/hmg/dds299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds299</ArticleId><ArticleId IdType="pmc">PMC3471393</ArticleId><ArticleId IdType="pubmed">22833456</ArticleId></ArticleIdList></Reference><Reference><Citation>Thau N., Knippenberg S., K&#xf6;rner S., Rath K.J., Dengler R., Petri S. Decreased MRNA expression of PGC-1&#x3b1; and PGC-1&#x3b1;-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J. Neuropathol. Exp. Neurol. 2012;71:1064&#x2013;1074. doi: 10.1097/NEN.0b013e318275df4b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318275df4b</ArticleId><ArticleId IdType="pubmed">23147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Song Y., Kincaid B., Bossy B., Bossy-Wetzel E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1&#x3b1;. Neurobiol. Dis. 2013;51:72&#x2013;81. doi: 10.1016/j.nbd.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.07.004</ArticleId><ArticleId IdType="pmc">PMC3992938</ArticleId><ArticleId IdType="pubmed">22819776</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatori I., Valle C., Ferri A., Carr&#xec; M.T. SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochem. Int. 2017;109:184&#x2013;192. doi: 10.1016/j.neuint.2017.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.04.012</ArticleId><ArticleId IdType="pubmed">28449871</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Pradat P.-F., Ludolph A.C., Loeffler J.-P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape J.A., Grose J.H. The effects of diet and sex in amyotrophic lateral sclerosis. Rev. Neurol. 2020;176:301&#x2013;315. doi: 10.1016/j.neurol.2019.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes E.T., Perurena O.H., Festoff B.W., Jorgensen R., Moore W.V. Insulin resistance in amyotrophic lateral sclerosis. J. Neurol. Sci. 1984;63:317&#x2013;324. doi: 10.1016/0022-510X(84)90154-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(84)90154-0</ArticleId><ArticleId IdType="pubmed">6374040</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.-F., Bruneteau G., Gordon P.H., Dupuis L., Bonnefont-Rousselot D., Simon D., Salachas F., Corcia P., Frochot V., Lacorte J.-M., et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:166&#x2013;171. doi: 10.3109/17482960902822960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Steyn F.J., Ngo S.T., Borges K. CNS glucose metabolism in amyotrophic lateral sclerosis: A therapeutic target? Cell Bio. Sci. 2021;11:14. doi: 10.1186/s13578-020-00511-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00511-2</ArticleId><ArticleId IdType="pmc">PMC7798275</ArticleId><ArticleId IdType="pubmed">33431046</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Borges K. Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the HSOD1G93A mouse model of amyotrophic lateral sclerosis. J. Cereb. Blood Flow Metab. 2019;39:1710&#x2013;1724. doi: 10.1177/0271678X18764775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X18764775</ArticleId><ArticleId IdType="pmc">PMC6727138</ArticleId><ArticleId IdType="pubmed">29553298</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Lange D.J., Voustianiouk A., MacGrogan D., Ho L., Suh J., Humala N., Thiyagarajan M., Wang J., Pasinetti G.M. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC NeuroSci. 2006;7:29. doi: 10.1186/1471-2202-7-29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-7-29</ArticleId><ArticleId IdType="pmc">PMC1488864</ArticleId><ArticleId IdType="pubmed">16584562</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewsbury L.S., Lim C.K., Steiner G.Z. The efficacy of ketogenic therapies in the clinical management of people with neurodegenerative disease: A systematic review. Adv. Nutr. 2021 doi: 10.1093/advances/nmaa180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmaa180</ArticleId><ArticleId IdType="pubmed">33621313</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink J.H., Kalmijn S., Groeneveld G.-J., Wunderink W., Koster A., de Vries J.H.M., van der Luyt J., Wokke J.H.J., Van den Berg L.H. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2007;78:367&#x2013;371. doi: 10.1136/jnnp.2005.083378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.083378</ArticleId><ArticleId IdType="pmc">PMC2077791</ArticleId><ArticleId IdType="pubmed">16648143</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.C., O&#x2019;Reilly &#xc9;.J., Falcone G.J., McCullough M.L., Park Y., Kolonel L.N., Ascherio A. Dietary &#x3c9;-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:1102&#x2013;1110. doi: 10.1001/jamaneurol.2014.1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1214</ArticleId><ArticleId IdType="pmc">PMC4160351</ArticleId><ArticleId IdType="pubmed">25023276</ArticleId></ArticleIdList></Reference><Reference><Citation>Maalouf M., Sullivan P.G., Davis L., Kim D.Y., Rho J.M. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 2007;145:256&#x2013;264. doi: 10.1016/j.neuroscience.2006.11.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2006.11.065</ArticleId><ArticleId IdType="pmc">PMC1865572</ArticleId><ArticleId IdType="pubmed">17240074</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai S.-I., Guarente L. It takes two to tango: NAD+ and sirtuins in aging/longevity control. NPJ Aging Mech. Dis. 2016;2:16017. doi: 10.1038/npjamd.2016.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npjamd.2016.17</ArticleId><ArticleId IdType="pmc">PMC5514996</ArticleId><ArticleId IdType="pubmed">28721271</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimazu T., Hirschey M.D., Hua L., Dittenhafer-Reed K.E., Schwer B., Lombard D.B., Li Y., Bunkenborg J., Alt F.W., Denu J.M., et al. SIRT3 deacetylates mitochondrial 3-Hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 2010;12:654&#x2013;661. doi: 10.1016/j.cmet.2010.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2010.11.003</ArticleId><ArticleId IdType="pmc">PMC3310379</ArticleId><ArticleId IdType="pubmed">21109197</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinetti G.M., Bilski A.E., Zhao W. Sirtuins as therapeutic targets of ALS. Cell Res. 2013;23:1073&#x2013;1074. doi: 10.1038/cr.2013.94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2013.94</ArticleId><ArticleId IdType="pmc">PMC3760621</ArticleId><ArticleId IdType="pubmed">23856645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B.L. Could sirtuin activities modify ALS onset and progression? Cell. Mol. Neurobiol. 2017;37:1147&#x2013;1160. doi: 10.1007/s10571-016-0452-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-016-0452-2</ArticleId><ArticleId IdType="pubmed">27942908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd A.C., Keeney P.M., Govind M.M., Bennett J.P. Mitochondrial oxidative phosphorylation transcriptome alterations in human amyotrophic lateral sclerosis spinal cord and blood. Neuromol. Med. 2014;16:714&#x2013;726. doi: 10.1007/s12017-014-8321-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-014-8321-y</ArticleId><ArticleId IdType="pubmed">25081190</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.T. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol. Res. 2017;39:73&#x2013;82. doi: 10.1080/01616412.2016.1251711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2016.1251711</ArticleId><ArticleId IdType="pubmed">27809706</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrera-Juli&#xe1; S., Moreno M.L., Barrios C., de la Rubia Ort&#xed; J.E., Drehmer E. Antioxidant alternatives in the treatment of amyotrophic lateral sclerosis: A comprehensive review. Front. Physiol. 2020;11:63. doi: 10.3389/fphys.2020.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00063</ArticleId><ArticleId IdType="pmc">PMC7016185</ArticleId><ArticleId IdType="pubmed">32116773</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Rubia J.E., Drehmer E., Platero J.L., Benlloch M., Caplliure-Llopis J., Villaron-Casales C., de Bernardo N., Alarc&#xd3;n J., Fuente C., Carrera S., et al. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: A randomized, double-blind, placebo-controlled human pilot study. Amyotroph. Lateral Scler. Front. Degener. 2019:1&#x2013;8. doi: 10.1080/21678421.2018.1536152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1536152</ArticleId><ArticleId IdType="pubmed">30668199</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibye-Knudsen M., Fang E.F., Croteau D.L., Bohr V.A. Contribution of defective mitophagy to the neurodegeneration in DNA repair-deficient disorders. Autophagy. 2014;10:1468&#x2013;1469. doi: 10.4161/auto.29321.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.29321</ArticleId><ArticleId IdType="pmc">PMC4203523</ArticleId><ArticleId IdType="pubmed">24991831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosawa K., Shibata H., Hayashi N., Sato N., Kamada T., Tagawa K. Kinetics of hydroperoxide degradation by NADP-glutathione system in mitochondria. J. Biochem. 1990;108:9&#x2013;16. doi: 10.1093/oxfordjournals.jbchem.a123169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.jbchem.a123169</ArticleId><ArticleId IdType="pubmed">2229015</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin F., Sancheti H., Cadenas E. Mitochondrial thiols in the regulation of cell death pathways. Antioxid. Redox Signal. 2012;17:1714&#x2013;1727. doi: 10.1089/ars.2012.4639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.4639</ArticleId><ArticleId IdType="pmc">PMC3474184</ArticleId><ArticleId IdType="pubmed">22530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Holmgren A. The thioredoxin antioxidant system. Free Radic. Biol. Med. 2014;66:75&#x2013;87. doi: 10.1016/j.freeradbiomed.2013.07.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.07.036</ArticleId><ArticleId IdType="pubmed">23899494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilari S., Giancotti L.A., Lauro F., Dagostino C., Gliozzi M., Malafoglia V., Sansone L., Palma E., Tafani M., Russo M.A., et al. Antioxidant modulation of sirtuin 3 during acute inflammatory pain: The ROS control. Pharmacol. Res. 2020;157:104851. doi: 10.1016/j.phrs.2020.104851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104851</ArticleId><ArticleId IdType="pubmed">32423865</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A.R., Walters R., Waldron F.M., Pal S., Selvaraj B.T., Macleod M.R., Hardingham G.E., Chandran S., Gregory J.M. Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: A systematic review and meta-analysis. Brain Commun. 2019;1:fcz009. doi: 10.1093/braincomms/fcz009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcz009</ArticleId><ArticleId IdType="pmc">PMC7056361</ArticleId><ArticleId IdType="pubmed">32133457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramis M.R., Esteban S., Miralles A., Tan D.-X., Reiter R.J. Protective effects of melatonin and mitochondria-targeted antioxidants against oxidative stress: A review. Curr. Med. Chem. 2015;22:2690&#x2013;2711. doi: 10.2174/0929867322666150619104143.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867322666150619104143</ArticleId><ArticleId IdType="pubmed">26087763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bald E.M., Nance C.S., Schultz J.L. Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the pooled resource open-access ALS clinic trials database. Muscle Nerve. 2021;63:572&#x2013;576. doi: 10.1002/mus.27168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27168</ArticleId><ArticleId IdType="pubmed">33428242</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Cheng J., Wang S., Wang X., Jiang H., Yang Y., Wang Y., Zhang C., Liang W., Feng H. &#x3b1;-Lipoic acid attenuates oxidative stress and neurotoxicity via the ERK/Akt-dependent pathway in the mutant HSOD1 related drosophila model and the NSC34 cell line of amyotrophic lateral sclerosis. Brain Res. Bull. 2018;140:299&#x2013;310. doi: 10.1016/j.brainresbull.2018.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.05.019</ArticleId><ArticleId IdType="pubmed">29842900</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C., Danel V., Devedjian J.C., Grolez G., Timmerman K., Laloux C., Petrault M., Gouel F., Jonneaux A., Dutheil M., et al. Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis? Antioxid. Redox Signal. 2018;29:742&#x2013;748. doi: 10.1089/ars.2017.7493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7493</ArticleId><ArticleId IdType="pmc">PMC6067092</ArticleId><ArticleId IdType="pubmed">29287521</ArticleId></ArticleIdList></Reference><Reference><Citation>Skulachev V.P., Antonenko Y.N., Cherepanov D.A., Chernyak B.V., Izyumov D.S., Khailova L.S., Klishin S.S., Korshunova G.A., Lyamzaev K.G., Pletjushkina O.Y., et al. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs) Biochim. Biophys. Acta. 2010;1797:878&#x2013;889. doi: 10.1016/j.bbabio.2010.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2010.03.015</ArticleId><ArticleId IdType="pubmed">20307489</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel E., Cassina A., Mart&#xed;nez-Palma L., Souza J.M., Bolatto C., Rodr&#xed;guez-Bottero S., Logan A., Smith R.A.J., Murphy M.P., Barbeito L., et al. Neuroprotective effects of the mitochondria-targeted antioxidant mitoq in a model of inherited amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2014;70:204&#x2013;213. doi: 10.1016/j.freeradbiomed.2014.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.02.019</ArticleId><ArticleId IdType="pubmed">24582549</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattee G.L., Post G.R., Gerber R.E., Bennett J.P. Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2003;4:90&#x2013;95. doi: 10.1080/14660820310012736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310012736</ArticleId><ArticleId IdType="pubmed">14506939</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumi Y., Sawada H., Yamamoto N., Kume T., Katsuki H., Shimohama S., Akaike A. Novel neuroprotective mechanisms of pramipexole, an anti-parkinson drug, against endogenous dopamine-mediated excitotoxicity. Eur. J. Pharmacol. 2007;557:132&#x2013;140. doi: 10.1016/j.ejphar.2006.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2006.11.011</ArticleId><ArticleId IdType="pubmed">17161393</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnicki S.A., Berry J.D., Ingersoll E., Archibald D., Cudkowicz M.E., Kerr D.A., Dong Y. Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a phase II study: Subgroup analysis of demographic and clinical characteristics. Amyotroph. Lateral Scler. Front. Degener. 2013;14:44&#x2013;51. doi: 10.3109/17482968.2012.723723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.723723</ArticleId><ArticleId IdType="pubmed">22985432</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R., Akiyama T., Hadano S., Aoki M., Saya H., Sobue G., et al. Modeling sporadic ALS in IPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.Y., Lee J.-H., Chung A.-Y., Jo Y., Shin J.-H., Park H.-C., Kim H., Lopez-Gonzalez R., Ryu J.R., Sun W. Prevention of mitochondrial impairment by inhibition of protein phosphatase 1 activity in amyotrophic lateral sclerosis. Cell Death Dis. 2020;11:888. doi: 10.1038/s41419-020-03102-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03102-8</ArticleId><ArticleId IdType="pmc">PMC7578657</ArticleId><ArticleId IdType="pubmed">33087694</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreux P.A., Blanco-Bose W., Ryu D., Burdet F., Ibberson M., Aebischer P., Auwerx J., Singh A., Rinsch C. The mitophagy activator urolithin a is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat. Metab. 2019;1:595&#x2013;603. doi: 10.1038/s42255-019-0073-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-019-0073-4</ArticleId><ArticleId IdType="pubmed">32694802</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Zhang M., Dai Y., Sun Y., Aman Y., Xu Y., Yu P., Zheng Y., Yang J., Zhu X. Spermidine inhibits neurodegeneration and delays aging via the PINK1-PDR1-dependent mitophagy pathway in C. elegans. Aging. 2020;12:16852&#x2013;16866. doi: 10.18632/aging.103578.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103578</ArticleId><ArticleId IdType="pmc">PMC7521492</ArticleId><ArticleId IdType="pubmed">32902411</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Gao S., Kang Z., Zhang M., Zhao X., Zhai Y., Huang J., Yang G.-Y., Sun W., Wang J. Rapamycin enhances mitophagy and attenuates apoptosis after spinal ischemia-reperfusion injury. Front. NeuroSci. 2018;12:865. doi: 10.3389/fnins.2018.00865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00865</ArticleId><ArticleId IdType="pmc">PMC6286985</ArticleId><ArticleId IdType="pubmed">30559639</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharath L.P., Agrawal M., McCambridge G., Nicholas D.A., Hasturk H., Liu J., Jiang K., Liu R., Guo Z., Deeney J., et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation. Cell Metab. 2020;32:44&#x2013;55.e6. doi: 10.1016/j.cmet.2020.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.04.015</ArticleId><ArticleId IdType="pmc">PMC7217133</ArticleId><ArticleId IdType="pubmed">32402267</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis. IDrugs. 2010;13:568&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3058503</ArticleId><ArticleId IdType="pubmed">20721828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S., Peterson P.K., Chao C.C. Cytokine-mediated neuronal apoptosis. Neurochem. Int. 1997;30:427&#x2013;431. doi: 10.1016/S0197-0186(96)00078-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-0186(96)00078-2</ArticleId><ArticleId IdType="pubmed">9106257</ArticleId></ArticleIdList></Reference><Reference><Citation>Goossens V., Grooten J., Vos K.D., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA. 1995;92:8115&#x2013;8119. doi: 10.1073/pnas.92.18.8115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.18.8115</ArticleId><ArticleId IdType="pmc">PMC41106</ArticleId><ArticleId IdType="pubmed">7667254</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-N&#xfa;&#xf1;ez R., Babdor J., Maciel T.T., Guillo M., Gros L., Dubreuil P., D&#xed;az-Amarilla P., Cassina P., et al. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J. Neuroinflamm. 2016;13:177. doi: 10.1186/s12974-016-0620-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0620-9</ArticleId><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Hendrix S., Dickson S.P., Knowlton N., Macklin E.A., Berry J.D., Elliott M.A., Maiser S., Karam C., Caress J.B., et al. Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis. Muscle Nerve. 2021;63:31&#x2013;39. doi: 10.1002/mus.27091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27091</ArticleId><ArticleId IdType="pmc">PMC7820979</ArticleId><ArticleId IdType="pubmed">33063909</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wang H., Ying Z., Gao Q. Ibudilast enhances the clearance of SOD1 and TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: The new molecular mechanism of ibudilast and its implication for neuroprotective therapy. Biochem. Biophys. Res. Commun. 2020;526:231&#x2013;238. doi: 10.1016/j.bbrc.2020.03.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.051</ArticleId><ArticleId IdType="pubmed">32204915</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>